We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Mereo Biopharma Group Plc | LSE:MPH | London | Ordinary Share | GB00BZ4G2K23 | ORD GBP0.003 (REG S) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 26.50 | 26.00 | 27.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMMPH
RNS Number : 6911B
Mereo BioPharma Group plc
09 October 2020
Mereo BioPharma Group plc
Director and PDMR Dealings
London and Redwood City, Calif ., October 9, 2020 - Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), "Mereo" or "the Company", a clinical-stage biopharmaceutical company focused on oncology and rare diseases, received notification that on October 7 2020 Denise Scots-Knight, Chief Executive Officer of Mereo, purchased 12,711 American Depositary Shares (ADSs) at a price of USD 2.36 per ADS, Brian Schwartz, Non-Executive Director of Mereo, purchased 20,000 ADSs at a price of USD 2.35 per ADS and John Richard, Head of Corporate Development of Mereo, purchased 6,500 ADSs at a price of USD 2.36 per ADS.
The below announcement and notification is made in accordance with the EU Market Abuse Regulation. The form required under the EU Market Abuse Regulation follows.
Hot Features
Premium
1 Details of the person discharging managerial responsibilities
a) Name Denise Scots-Knight
------------------------- ----------------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------
a) Position/status Chief Executive Officer
------------------------- ----------------------------------------------
b) Initial notification/ Initial notification
Amendment
------------------------- ----------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------
a) Name Mereo BioPharma Group plc
------------------------- ----------------------------------------------
b) LEI 213800U8JQHIJOS5AS09
------------------------- ----------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
-------------------------------------------------------------------------
a) Description of MEREO BIOPHARMA GROUP PLC AMERICAN DEPOSITARY
the financial SHARES (ADSs)
instrument, type
of instrument
and identification
code
------------------------- ----------------------------------------------
b) Nature of the PURCHASE
transaction
------------------------- ----------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) USD 2.36 12,711
----------
------------------------- ----------------------------------------------
Aggregated information:
d) volume, Price 30043.72
------------------------- ----------------------------------------------
e) Date of the transaction 2020-10-07
------------------------- ----------------------------------------------
f) Place of the XNMS
transaction
------------------------- ----------------------------------------------
1 Details of the person discharging managerial responsibilities
a) Name Brian Schwartz
------------------------- ----------------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------
a) Position/status Non-Executive Director
------------------------- ----------------------------------------------
b) Initial notification/ Initial notification
Amendment
------------------------- ----------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------
a) Name Mereo BioPharma Group plc
------------------------- ----------------------------------------------
b) LEI 213800U8JQHIJOS5AS09
------------------------- ----------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
-------------------------------------------------------------------------
a) Description of MEREO BIOPHARMA GROUP PLC AMERICAN DEPOSITARY
the financial SHARES (ADSs)
instrument, type
of instrument
and identification
code
------------------------- ----------------------------------------------
b) Nature of the PURCHASE
transaction
------------------------- ----------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) USD 2.35 20,000
----------
------------------------- ----------------------------------------------
Aggregated information:
d) volume, Price 47068.00
------------------------- ----------------------------------------------
e) Date of the transaction 2020-10-07
------------------------- ----------------------------------------------
f) Place of the XNMS
transaction
------------------------- ----------------------------------------------
1 Details of the person discharging managerial responsibilities
a) Name John Richard
------------------------- ----------------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------
a) Position/status Head of Corporate Development
------------------------- ----------------------------------------------
b) Initial notification/ Initial notification
Amendment
------------------------- ----------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------
a) Name Mereo BioPharma Group plc
------------------------- ----------------------------------------------
b) LEI 213800U8JQHIJOS5AS09
------------------------- ----------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
-------------------------------------------------------------------------
a) Description of MEREO BIOPHARMA GROUP PLC AMERICAN DEPOSITARY
the financial SHARES (ADSs)
instrument, type
of instrument
and identification
code
------------------------- ----------------------------------------------
b) Nature of the PURCHASE
transaction
------------------------- ----------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) USD 2.36 6,500
----------
------------------------- ----------------------------------------------
Aggregated information:
d) volume, Price 15330.06
------------------------- ----------------------------------------------
e) Date of the transaction 2020-10-07
------------------------- ----------------------------------------------
f) Place of the XNMS
transaction
------------------------- ----------------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHEKLFBBBLBFBZ
(END) Dow Jones Newswires
October 09, 2020 11:05 ET (15:05 GMT)
1 Year Mereo Biopharma Chart |
1 Month Mereo Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
